About Us
Swiss Startup
MUGENBIO is a Medtech startup based in Kanton Zurich, Switzerland.
Our mission is to break technological barriers in the way of medical diagnostics. We are developing novel biotechnologies, which enable more senstive and specific medical diagnostics of male cancers.
Knowledge and Vision
We are aware of huge limitations of the current medical diagnostics of male cancers. We understand that improved method for early diagnosis of prostate cancer is urgently needed. We also have all the knowledge, expertise and vision perquisite to deliver such novel technology. This is why MUGENBIO develops innovations, which will improve prostate cancer diagnostic and save many lives in the future.
Strategy and Future
Performance of novel technology often depends on totality of innovative solutions integrated in the final product. Unlike our competitors, we are not focused on searching for single innovation, which will improve current screening of prostate cancer. Our diagnostic platform is developed according to comprehensive R&D program, which integrates multiple innovations. We believe that the above approach will lead to successful development of the next-generation prostate cancer diagnostic platform.